Ceramide synthase 6 (CERS6) alleviates insulin resistance, increases systemic energy expenditure, and maintains glucose homeostasis by improving β-oxidation capacity in liver and brown adipose tissues (Raichur et al., 2019). The gene discussed is CERS6; the disease is Insulin resistance.